About Us
Author Guidelines
Contact Us
Supplier Info
 


Current Issue
Sample issue of JATCurrent Issue


Contact Info:
6600 W. Touhy Ave.
Niles, IL 60714
Tel: 847.647.2900
Fax: 847.647.1155
circulation@jatox.com

 

 
   

Journal of Analytical Toxicology Article Abstracts

Journal of Analytical Toxicology Horizontal Line

Published: Journal of Analytical Toxicology, ISSN 0146-4760, Volume 45, Number 7, September, pp.369-376

Simultaneous Analysis of 14 Benzodiazepines in Oral Fluid by Solid-Phase Extraction and LC–MS–MS
George Ngwa[1], Dean Fritch[2], Kristen Blum[2], Gregory Newland[3]
[1]Chemistry, Lehigh University, 6 E. Packer Ave., Seeley G. Mudd Building, Bethlehem, Pennsylvania 18015
[2]OraSure Technologies, Research and Development, Bethlehem, Pennsylvania
[3]Applied Biosystems, Applied Markets/Small Molecules, 21 S. 8th St., Bangor, Pennsylvania 18013

A simple and rapid procedure for the simultaneous screening of 14 benzodiazepines in oral fluid is presented. The procedure involves a solid-phase extraction followed by liquid chromatography–tandem mass spectrometry (LC––MS––MS). The target compounds include diazepam, oxazepam, temazepam, nordiazepam, lorazepam, chlordiazepoxide, alprazolam, a-hydroxyalprazolam, desalkylflurazepam, hydroxyethylflurazepam, clonazepam, 7-aminoclonazepam, flunitrazepam, and 7-aminoflunitrazepam. Oral fluid was obtained using a simple device that collects approximately 0.4 mL of oral fluid and dilutes it with 0.8 mL of preservative. The oral fluid sample preparation involves a solid-phase extraction on a Varian Bond Elut cartridge. Quantitation was performed by LC––MS––MS using nordiazepam-d5 as the internal standard. The extraction efficiency exceeded 83% for all compounds except for 7-aminoclonazepam, which had a recovery of 55%. The limits of quantitation ranged from 0.1 ng/mL to 1.0 ng/mL in the multiple reaction monitoring mode. This method was used to confirm 41 patients that screened positive using the OraSure Technologies Benzodiazepine Intercept® MICRO-PLATE Enzyme Immunoassay kit. All screened-positive patients were positive for at least one of the analyzed benzodiazepines, thus showing that this method is suitable for confirmation of the Intercept Benzodiazepine assay.

Reproduction of editorial content of this journal is prohibited without publisher’s permission.

This article is available in its entirety by fax for $4.00 per page.
Visa or MasterCard accepted.

To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.

Please indicate JAT volume and issue along with page numbers.


| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |